We are pleased to welcome Dr Fabio Turatti to Phenomics Australia’s Board of Directors. Fabio brings extensive experience in the high-innovation startup ecosystem, along with exceptional leadership skills that will strengthen our team.
His insights and expertise will play a key role in advancing our vision of improving health outcomes through the discovery of gene function. Fabio’s strategic guidance will also help deepen our investments in cutting-edge technologies, ensuring we continue to meet the evolving needs of our users and stakeholders.
Together, we look forward to addressing Australia’s most pressing health challenges and expanding our impact globally.
Please join us in welcoming Fabio to the team!

Meet Fabio
Fabio is a C-suite executive with extensive experience in Australia’s high-innovation startup ecosystem. After completing his education in Australia, he spent a decade in Europe developing and managing advanced technology platforms before returning home in 2007.
Currently, Fabio is the Founding Partner and Managing Director of SYNthesis BioVentures, an ESVCLP investment fund focusing on early-stage Australian therapeutics companies. He transitioned to this role in 2022 after serving as COO (2013-2021) and CEO (2021-present) of SYNthesis Research.
His expertise spans licensing, partnering transactions, startup funding, investment strategies, and risk analysis. He serves as an advisor, founder, or board member for several companies, including Catalyst Therapeutics, Anaxis Pharma, Qubist Molecular Design, Aculeus Therapeutics, Qubigen and Melbridge Therapeutics.
Thank you and best wishes to former Phenomics Australia Board member Dr Susan Pond
On behalf of the Phenomics Australia team, we want to extend our heartfelt thanks for the invaluable contributions Dr Pond made during her time on our board. Her dedication, insights, and leadership have been instrumental in shaping our success.
As she moves on to her next chapter, we wish her nothing but the best in her new endeavours. We’re confident she’ll continue to achieve great things, and we hope our paths cross again in the future.

Thank you once again for everything.
Warm regards,
Phenomics Australia team